Latest news with #400.00
Business Insider
15 hours ago
- Business
- Business Insider
UBS Sticks to Their Buy Rating for Takeuchi Mfg.Co., Ltd. (6432)
UBS analyst Tsubasa Sasaki maintained a Buy rating on Takeuchi Ltd. (6432 – Research Report) today and set a price target of Yen5,540.00. The company's shares closed today at Yen4,400.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sasaki is a 3-star analyst with an average return of 6.2% and a 50.00% success rate. Sasaki covers the Industrials sector, focusing on stocks such as Makino Milling Machine Co, AMADA HOLDINGS CO, and Hitachi Construction Machinery Co. The word on The Street in general, suggests a Hold analyst consensus rating for Takeuchi Ltd..
Business Insider
16 hours ago
- Business
- Business Insider
Morgan Stanley Sticks to Their Buy Rating for COSMOS Pharmaceutical Corporation (3349)
In a report released today, Ai Furukawa from Morgan Stanley maintained a Buy rating on COSMOS Pharmaceutical Corporation (3349 – Research Report), with a price target of Yen10,400.00. The company's shares closed today at Yen9,062.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Furukawa is an analyst with an average return of -5.5% and a 60.00% success rate. Furukawa covers the Consumer Cyclical sector, focusing on stocks such as ABC-MART, Asics, and Isetan Mitsukoshi Holdings. Currently, the analyst consensus on COSMOS Pharmaceutical Corporation is a Hold with an average price target of Yen9,825.00, which is an 8.42% upside from current levels. In a report released on June 13, Citi also maintained a Buy rating on the stock with a Yen11,200.00 price target.
Business Insider
a day ago
- Business
- Business Insider
LTIMindtree Limited (LTIM) Gets a Hold from Morgan Stanley
Morgan Stanley analyst Sulabh Govila maintained a Hold rating on LTIMindtree Limited (LTIM – Research Report) today and set a price target of INR5,400.00. The company's shares closed today at INR5,450.50. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Govila is an analyst with an average return of -5.4% and a 30.00% success rate. Govila covers the Technology sector, focusing on stocks such as LTIMindtree Limited, Cyient Limited, and L&T Technology Services Ltd.. The word on The Street in general, suggests a Hold analyst consensus rating for LTIMindtree Limited with a INR4,971.15 average price target. The company has a one-year high of INR6,764.80 and a one-year low of INR3,841.05. Currently, LTIMindtree Limited has an average volume of 13.91K.
Business Insider
4 days ago
- Business
- Business Insider
Citi Sticks to Their Buy Rating for Recruit Holdings Co (RCRRF)
Citi analyst Keiichi Yoneshima maintained a Buy rating on Recruit Holdings Co (RCRRF – Research Report) today and set a price target of Yen10,400.00. The company's shares closed last Friday at $54.67. Confident Investing Starts Here: In addition to Citi, Recruit Holdings Co also received a Buy from J.P. Morgan's Junko Yamamura CFA in a report issued on June 3. However, on the same day, Nomura maintained a Hold rating on Recruit Holdings Co (Other OTC: RCRRF). Based on Recruit Holdings Co's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $861.78 billion and a net profit of $66.96 billion. In comparison, last year the company earned a revenue of $843.78 billion and had a net profit of $34.22 billion
Business Insider
02-06-2025
- Business
- Business Insider
Daiichi Sankyo Company (DSKYF) Receives a Buy from Bernstein
Bernstein analyst Miki Sogi maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen6,400.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sogi is an analyst with an average return of -1.9% and a 45.45% success rate. Sogi covers the Healthcare sector, focusing on stocks such as Daiichi Sankyo Company, Astellas Pharma, and Chugai Pharmaceutical Co. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Daiichi Sankyo Company with a $40.43 average price target. The company has a one-year high of $44.64 and a one-year low of $20.15. Currently, Daiichi Sankyo Company has an average volume of 76.67K.
